Long-term benefit of COMT inhibition in Parkinson's disease patients switched from tolcapone to entacapone

被引:0
|
作者
Bellino, A
Antonini, A
Sacilotto, G
Meucci, N
Pezzoli, G
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:A279 / A279
页数:1
相关论文
共 50 条
  • [1] Long-term comparative experience with tolcapone and entacapone in advanced Parkinson's disease
    Factor, SA
    Molho, ES
    Feustel, PJ
    Brown, DL
    Evans, SM
    [J]. CLINICAL NEUROPHARMACOLOGY, 2001, 24 (05) : 295 - 299
  • [2] Tolcapone treatment fluctuating patients with Parkinson's disease who did not benefit from entacapone
    Canesi, M.
    Zecchinelli, A. L.
    Pezzoli, G.
    Antonini, A.
    [J]. PARKINSONISM & RELATED DISORDERS, 2007, 13 : S101 - S101
  • [3] Tolcapone in the management of COMT inhibition failure in Parkinson's disease (PD)
    Iansek, R.
    Kirkwood, B.
    [J]. MOVEMENT DISORDERS, 2006, 21 : S485 - S486
  • [4] The effect of COMT inhibition with entacapone on cardiorespiratory responses to exercise in patients with Parkinson's disease
    Lyytinen, J
    Kaakkola, S
    Gordin, A
    Kultalahti, ER
    Teräväinen, H
    Sovijärvi, A
    [J]. PARKINSONISM & RELATED DISORDERS, 2002, 8 (05) : 349 - 355
  • [5] Switch-over from tolcapone to entacapone in severe Parkinson's disease patients
    Onofrj, M
    Thomas, A
    Iacono, D
    Di Iorio, A
    Bonanni, L
    [J]. EUROPEAN NEUROLOGY, 2001, 46 (01) : 11 - 16
  • [6] Benefit of tolcapone in patients with early Parkinson's disease
    Suchowersky, O
    Martin, WRW
    Bailey, P
    Argatoff, P
    Roberts, T
    Hodder, J
    Bailey, S
    Brant, R
    [J]. NEUROLOGY, 1996, 46 (02) : 4001 - 4001
  • [7] Long-term retention rate of entacapone in the treatment of Parkinson's disease
    Keraenen, T.
    Tuhkasaari, M.
    Kuusisto, H.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (04) : E30 - E30
  • [8] COMT genotype and effectiveness of entacapone in patients with fluctuating Parkinson's disease
    Lee, MS
    Kim, HS
    Cho, EK
    Lim, JH
    Rinne, JO
    [J]. NEUROLOGY, 2002, 58 (04) : 564 - 567
  • [9] Efficacy of tolcapone in patients switched from entacapone for treatment failure
    Iansek, R.
    Makutonina, M.
    DeSilva, C.
    [J]. MOVEMENT DISORDERS, 2006, 21 : S512 - S512
  • [10] Tolcapone in stable Parkinson's disease: Efficacy and safety of long-term treatment
    Waters, CH
    Kurth, M
    Bailey, P
    Shulman, LM
    LeWitt, P
    Dorflinger, E
    Deptula, D
    Pedder, S
    [J]. NEUROLOGY, 1997, 49 (03) : 665 - 671